Vivos (RDGL) Long-Term Investments (2010)
Vivos' (RDGL) quarterly Long-Term Investments came in at $10000.0 in Q4 2010.
Vivos (RDGL) Long-Term Investments (2010) Analysis & Trends
Vivos has disclosed Long-Term Investments across 1 years of filings, most recently posting $10000.0 for Q4 2010.
- Long-Term Investments for Q4 2010 came in at $10000.0, changed N/A year-over-year; the trailing twelve-month figure through Dec 2010 was $10000.0 (changed N/A YoY), and the FY2010 annual result was $10000.0, changed N/A from the prior year.
- Long-Term Investments came in at $10000.0 for Q4 2010 at Vivos.
- In the past five years, Long-Term Investments ranged from a high of $10000.0 in Q4 2010 to a low of $10000.0 in Q4 2010.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 1.09 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | - |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | - |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 285.60 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 166.25 Mn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | - |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | - |
| 10 | Vivos | - | - | -3,105.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2010 | 10,000.00 |